For independent cannabis operators, building a great product is only one part of the equation. Cultivators, processors, and brands are operating in an increasingly competitive market where price compression, crowded retail shelves, shifting consumer preferences, and complex wholesale relationships can make it difficult to turn product into sustainable revenue. Even when independent operators produce strong products, their success depends on the commercial infrastructure to consistently move inventory and protect margins.
The challenge doesn’t stem from a lack of information. Operators have access to more market, sales, and inventory data than ever before, but raw data does not automatically translate into better decisions. Knowing which accounts to target, how to structure wholesale pricing, where inventory is moving, when to follow up, and how to manage the sales cycle requires a disciplined process. Without that structure, sales efforts can become inconsistent, difficult to measure, and overly dependent on individual relationships or product knowledge.
For smaller and mid-size operators, building that infrastructure internally can also be a significant undertaking. Recruiting, training, and managing a traditional field sales team takes time and creates permanent overhead at a point when many operators are already under pressure to operate more efficiently. At the same time, buyers may determine what gets onto the shelf, but budtenders and retail teams can have a significant influence on what consumers ultimately choose.
That is where Cure-Level Growth Systems™ sees an opportunity. The company works with independent cannabis operators to identify gaps in their wholesale operations and install the sales processes, data-driven tools, and commercial infrastructure needed to compete more effectively. With a focus on disciplined sales execution, inventory velocity, analytics, and scalable systems, Cure-Level Growth Systems™ brings an approach informed by experience across established regulated life science industries and successful multistate cannabis operators.
In this edition of ACT LAB’s Vendor Voices series, Cure-Level Growth Systems™ shares its perspective on the challenges facing independent cannabis brands, the importance of data-driven wholesale strategy, and where the industry is headed next.
Meet Cure-Level Growth Systems: An ACT LAB Vendor Partner
Cure-Level Growth Systems™ is helping independent cannabis operators build the commercial infrastructure they need to compete in an increasingly competitive market. By combining data-driven strategy, disciplined sales processes, and technology-enabled wholesale infrastructure, the company helps cultivators, processors, and brands turn market data into actionable sales strategies, improve inventory velocity, and build more scalable wholesale operations.
ACT LAB spoke with Angelo Gabriele, Founder of Cure-Level Growth Systems™, who brings 28 years of sales background including nearly a decade of experience orchestrating high-level sales and commercial strategy across successful multistate cannabis operators. Cure-Level Growth Systems™ brings institutional-level discipline to independent operators, helping them replace inconsistent sales approaches with standardized processes, actionable intelligence, and the tools needed to build sustainable growth. With a focus on turning independent brands into industry leaders, the company is building a new model for cannabis sales infrastructure designed to give smaller operators access to the commercial capabilities traditionally available only to larger organizations.
Q&A: Cure-Level Growth Systems x ACT LAB
About Cure-Level Growth Systems
Q: What is Cure-Level Growth Systems™, and what markets do you serve?
A: Cure-Level Growth Systems™ diagnoses the skeletal gaps Independent Cannabis Operators have in their wholesale and provides the commercial sales infrastructure needed to compete. We have recently launched in NJ, and have strong relationships with procurement teams throughout PA, OH, MD, and MA.
Q: What sets the Cure-Level Growth Systems™ approach apart in the cannabis space?
A: Professional discipline sets the Cure-Level Growth Systems™ approach apart in the cannabis space. The proprietary Cure-Level Sales Edge™ eliminates inconsistent “vibe-selling,” and institutes a digitized, five-stage sales cycle structure. This framework imports KPI-driven methodologies from other established regulated life science industries directly to the front lines of cannabis.
How Cure-Level Growth Systems™ Supports Cannabis Brands
Q: Describe how your data-driven approach benefits independent cannabis brands?
A: Anyone can purchase data, there’s plenty of it out there, but Cure-Level Precision is what transforms raw numbers into actionable wholesale strategy. We ensure independent brands focus on the metrics that actually drive inventory velocity and profitability.
Q: How does Cure-Level Growth Systems™ support the wholesale sales cycle for independent cannabis brands?
A: Having spent almost a decade orchestrating high-level strategy across elite multi-state operators (MSOs), we bring an institutional-grade discipline to the table that this industry simply lacks. We swap out amateur guesswork “consulting” with a proprietary data-driven prospecting tool. Architecting dedicated client portals with a fully functioning CRM that ties directly into live inventory and fulfillment.
Q: What are the pain points independent cannabis cultivators, processors, and brands face and how can Cure-Level Growth Systems™ help overcome them?
A: Independents need to scale immediately to keep up with competitors, and Cure-Level Growth Systems™ installs a turn-key wholesale sales department without the permanent overhead of recruiting, training, and managing a traditional field sales team.
Independents are swimming in “raw data.” Cure-Level Growth Systems™ converts that data into actionable intelligence and execution. We’ve collaborated with a leading market research and data analytics firm specializing in the legal cannabis industry.
Finally, independents rely on “product enthusiasts” unable to navigate the stages of a sales cycle or even handle customer objections. Cure-Level Growth Systems™ implements a proven, rigorous and standardized sales framework that can be duplicated for any brand, product, and market.
Q: What questions do you often receive from cannabis producers?
A: Producers often ask questions regarding inventory velocity, wholesale pricing, and discounts, and how to avoid high customer A/R balances.
Q: How does your approach differ from other consultative partners?
A: You won’t get useless theory from us. Our approach is built on hard-won, real-world execution. Having commanded sales operations in the trenches of three successful MSOs, we combine high-level executive direction with the grit required to get deals closed and supply chains moving.
Q: Why is budtender education an important part of your strategy?
A: Buyers stock the shelves of my clients’ products, but budtenders are the ones who influence consumer choice. Direct education is essential to turning passive inventory into real retail sales velocity.
About Partnering with ACT LAB
Q: Why did you choose to work with ACT LAB?
A: Since my early days with Cresco in Pennsylvania, ACT LAB was the gold standard and still is. ACT LAB is a fixture in the cannabis industry, not a passing trend or fly-by-night lab popping up.
Looking Ahead: The Future of Cure-Level Growth Systems
Q: What industry trends do you see in cannabis in 2026 and beyond?
A: While flower is still king, fast-acting beverages and sublingual technologies are surging. Total active cannabis licenses, especially cultivation permits, are dropping and will continue to until definitive action is taken on the rescheduling front. The rescheduling will bring with it opportunities in the compliance department as pharmaceutical-grade standards will be mandated
Q: What are some regulatory or industry hurdles cannabis cultivators, processors, or brands should be preparing for now?
A: With widespread price compression squeezing operators’ margins, surviving brands can no longer rely on metrics that look good on paper; meaningful business success requires rigorous, data-driven inventory velocity management and automated B2B infrastructure.
Q: How do you plan to continue innovating in this space?
A: My vision is to architect the world’s most sophisticated commercial infrastructure for the cannabis industry, integrating high-velocity sales talent with precision analytics to scale independent brands into industry icons. To provide a plug-and-play, turn-key solution for small-medium cannabis operators by partnering with technology that has only been available to the big companies.
Drawing from years of driving commercial execution in institutional pharmaceuticals, I bring that same level of rigorous compliance, pipeline architecture, and field-sales discipline to an industry rapidly evolving toward CPG maturity. Stay tuned…
Building a Stronger Cannabis Supply Chain
The Cure-Level Growth Systems™ approach highlights an important reality for today’s cannabis operators: commercial success depends on more than producing a quality product. It requires disciplined sales execution, meaningful data, efficient operations, and trusted partners across the supply chain.
If your brand has hit a growth ceiling and you need a sales engine that scales, reach out to Angelo to explore how Cure-Level Growth Systems™ can help and request a Complimentary Preliminary Audit.
At ACT LAB, we share Cure-Level Growth Systems™ focus to help cannabis businesses make better decisions with reliable information. From compliance testing to data that supports quality and consistency, our goal is to be your trusted partner in delivering actionable data and consistent results.
If you’re looking for a testing partner that understands the demands of a changing cannabis market, contact ACT LAB to learn how we can support your business.
